Skip to content

Company information lookup

VIRALYTICS LIMITED (VLA)

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
VLA 0.270 -1.82% 0.270 0.280 0.275 0.275 0.270 21,450

VIRALYTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code VLA
Securities
Official Listing Date 15 October, 1986
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.viralytics.com/
Registered Office Address Company Matters, Level 12, 680 George St, Sydney, NSW, AUSTRALIA, 2000
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Mr Paul Hopper (Chairman)
Dr Malcolm McColl (CEO)
Dr Phillip Altman (Non Exec. Director)
Mr Peter Molloy (Non Exec. Director)
Dr Leonard Post (Non Exec. Director)
Company Secretary Ms Catherine Officer

VIRALYTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
01/09/2014   Appendix 3B 14 PDF
27/08/2014   VLA Full Year Financial Results and Operational Highlights 3 PDF
27/08/2014 asterix Appendix 4E and Financial Report 65 PDF
30/07/2014   Letter to Shareholders - Viralytics Newsletter July 2014 5 PDF
22/07/2014 asterix Appendix 4C - quarterly 5 PDF
19/06/2014   Viralytics Limited - Updated Securities Trading Policy 6 PDF
11/06/2014   Ceasing to be a substantial holder - HHL 4 PDF
11/06/2014   Change in substantial holding 4 PDF
03/06/2014 asterix Viralytics - Progress in CAVATAK Phase 2 Melanoma Trial 3 PDF
27/05/2014   Becoming a substantial holder from HHA 4 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
29 Aug 2014 0.275 1.85% 0.275 0.275 11,750
28 Aug 2014 0.270 0% 0.275 0.270 93,638
27 Aug 2014 0.270 1.89% 0.280 0.270 29,686
26 Aug 2014 0.265 -1.85% 0.280 0.265 59,742
25 Aug 2014 0.270 -1.82% 0.280 0.270 71,023

* Volume of shares shown represents only those shares traded on ASX.

VIRALYTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security VLA. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security VLA

Warrants & Structured Products

No warrants & Structured Products are available over the security VLA

ASX CFDs

No Contracts For Differences are available over the security VLA